abstract |
There is described a pharmaceutical composition comprising a compound having sodium cromoglycate like activity, as active ingredient, in combination with an aminosalicyclic acid or a pharmaceutically acceptable derivative thereof. There are also described packages containing the separate components of the composition and pharmaceutical formulations containing the composition. |